← All Aprea Therapeutics, INC filings

Aprea Therapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
APRE
Aprea Therapeutics, INC
DEF: Aprea Therapeutics Annual Meeting: Reverse Stock Split Proposed
Aprea Therapeutics, Inc. is holding its 2026 Annual Meeting of Stockholders on June 16, 2026, to vote on key proposals including a potential reverse stock split to maintain Nasdaq listing.
NASDAQ
APRE
Aprea Therapeutics, INC
DEFA14A: Aprea Therapeutics Sets Date for 2025 Annual Meeting, Outlines Voting Proposals
Aprea Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 5, 2025, with key proposals including the election of directors and ratification of the company's accounting firm.
NASDAQ
APRE
Aprea Therapeutics, INC
DEF: Aprea Therapeutics Sets Date for 2025 Annual Stockholders Meeting
Aprea Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 5, 2025, to vote on director elections, auditor ratification, executive compensation, and other matters.
NASDAQ
APRE
Aprea Therapeutics, INC
DEFA14A: Aprea Therapeutics Sets Date for 2024 Annual Meeting, Outlines Voting Matters
Aprea Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 20, 2024, with key voting items including the election of directors and ratification of the company's accounting firm.
NASDAQ
APRE
Aprea Therapeutics, INC
DEF 14A: Aprea Therapeutics Sets Date for 2024 Annual Stockholders Meeting
Aprea Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 20, 2024, covering director elections and auditor ratification.